Fineline Cube

Follow:
14435 Articles
AbbVie Enters Obesity Field with Gubra's GUB014295 Licensing Deal
CompanyDeals

AbbVie Enters Obesity Field with Gubra’s GUB014295 Licensing Deal

Zeiss Group's VISUMAX 800 with SMILE pro Software Approved by China's NMPA
CompanyMedical Device

Zeiss Group’s VISUMAX 800 with SMILE pro Software Approved by China’s NMPA

Laekna's LAE120 Receives FDA Approval for Solid Tumor Clinical Trials
CompanyDrug

Laekna’s LAE120 Receives FDA Approval for Solid Tumor Clinical Trials

SynerK's SNK-2726 Gets FDA Green Light for Phase I Hypertension Study
CompanyDrug

SynerK’s SNK-2726 Gets FDA Green Light for Phase I Hypertension Study

Omron Healthcare and China Jo-Jo Drugstores Launch Atrial Fibrillation Screening Zone
CompanyDeals

Omron Healthcare and China Jo-Jo Drugstores Launch Atrial Fibrillation Screening Zone

WORK Medical Chartwell Med Healthcare Investment
CompanyDeals

WORK Medical and Chartwell Med Partner on Investment Tools for Healthcare Projects

Innovent Biologics Doses First Patient in IBI363 Melanoma Study vs Keytruda
CompanyDrug

Innovent Biologics Doses First Patient in IBI363 Melanoma Study vs Keytruda

Eyebright Medtech Plans Private Placement to Expand Contact Lens Production
DealsDrug

Eyebright Medtech Plans Private Placement to Expand Contact Lens Production

Sinocelltech's Finotonlimab Gets NMPA Approval for Liver Cancer Treatment
CompanyDrug

Sinocelltech’s Finotonlimab Gets NMPA Approval for Liver Cancer Treatment

Danatlas Raises RMB 150M to Advance Synthetic Lethality Drug Pipeline
CompanyDeals

Danatlas Raises RMB 150M to Advance Synthetic Lethality Drug Pipeline

Magnet Biomedicine and Eli Lilly Partner on Molecular Glue Therapeutics
CompanyDeals

Magnet Biomedicine and Eli Lilly Partner on Molecular Glue Therapeutics

AstraZeneca and Amgen's Tezspire Shows Positive Results in Phase III Study
CompanyDrug

AstraZeneca and Amgen’s Tezspire Shows Positive Results in Phase III Study